Review
Published on 07 Jun 2021
Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.664349
- 75,015 views
- 55 citations
Type at least 3 characters
608 articles
Original Research
Published on 28 May 2021
Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648769
- 5,761 views
- 13 citations
Original Research
Published on 14 May 2021
Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.592184
- 3,953 views
- 13 citations
Original Research
Published on 04 May 2021
The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.624895
- 7,835 views
- 13 citations
Review
Published on 30 Apr 2021
Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.643619
- 12,076 views
- 15 citations
Review
Published on 27 Apr 2021
Intensive Care and Treatment of Severe Guillain–Barré Syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.608130
- 75,092 views
- 52 citations
Review
Published on 27 Apr 2021
On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.662110
- 17,684 views
- 23 citations
Original Research
Published on 26 Apr 2021
Knockout of Formyl Peptide Receptor-1 Attenuates Cigarette Smoke–Induced Airway Inflammation in Mice
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.632225
- 2,916 views
- 13 citations
Original Research
Published on 26 Apr 2021
Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669635
- 3,412 views
- 6 citations
Original Research
Published on 23 Apr 2021
The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.668902
- 5,372 views
- 4 citations
Original Research
Published on 23 Apr 2021
Leflunomide Induces Dose-Dependent Lung Injury in Mice via Stimulating Vimentin and NLRP3 Inflammasome Production
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.631216
- 5,209 views
- 6 citations
Mini Review
Published on 23 Apr 2021
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.642822
- 8,870 views
- 49 citations
Perspective
Published on 21 Apr 2021
Gene Therapy: A Possible Alternative to CFTR Modulators?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648203
- 14,746 views
- 8 citations
Perspective
Published on 20 Apr 2021
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.652688
- 137,890 views
- 163 citations
Mini Review
Published on 20 Apr 2021
Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648506
- 5,428 views
- 7 citations
Original Research
Published on 19 Apr 2021
miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.551839
- 4,818 views
- 14 citations